Our Officers & Directors
We have a team of dedicated professionals who understand their goal is to respect the interests all shareholders while maximizing the market opportunity.
Mr. Ron Riewold | Chairman – Board of Directors
Mr. Riewold has extensive experience in operating and developing both public (Amex and NASDAQ) and private companies. Specifically, his expertise is in field or practice-level health care company operations. He was a top executive of six companies since 1978, three in the finance and real estate sector, and three in the health care and technology arena. Mr. Riewold has completed over fifty mergers in the health care industry.
After successfully growing a financial services company and real estate development company as CEO, Riewold entered the healthcare arena full time in 1996, as vice president of corporate development with Heart Labs of America, which became Medical Industries of America and later Cyber Care.
Upon leaving Cyber Care Riewold became a consultant for American Enterprise Solutions, Inc. a healthcare delivery system and Internet utility focusing on connectivity in the healthcare industry from 1999 – 2001. Vice President to President and then Chief Executive Officer in a short ten-month period.
In 2001, Mr. Riewold joined Pain Care Holdings as one of its original investors, President, Co-Chief Executive Officer and member of the board of directors. Riewold helped Pain Care rise from a start-up to an $80 million-dollar company that developed a process that protects by monitors patient including residents in nursing home/rehabilitation facilities or hospitals.
In 2008, he started Dynamic Real Estate Development as CEO focusing on development of medical buildings while partnering with physician groups and/or providing his expertise as a fee developer. His firm’s projects included surgery suites, urgent care facilities, and orthopedic offices.
From 2011 and to the present, Mr. Riewold founded and is President and CEO of Averlent Corporation, a national medication management initiative. In a few short months after its founding the company added several new clients including Accountable Care Organizations, larger group practices and over 500 Independent Physician Associations.
Mr. Riewold earned a bachelor’s degree from Florida State University 1970, and a Master of Business Administration from Temple University, 1972.
Mr. Jim Crone | President / Member – Board of Directors
Age 54, is an expert in advertising and digital marketing with stints at BBDO, Ogilvy & Mather, and other entrepreneurial agencies, as well as in-house roles at Prodigy and SAP Ventures. He has implemented both digital and traditional advertising for clients such as IBM, Mitsubishi, Turner Entertainment, Alere Healthcare and Ferrari. Mr. Crone attended the United States Military Academy at West Point and holds a BBA & MBA from Pace University.
Non-Executive Advisory Board
Mr. Phillip Giordano
Owner of a compounding pharmacy in Boca Raton, Florida which specializes in both veterinary medicine as well as specialized human medications. He is a licensed pharmacist, and has advised the Company since the formation of Newco4pharmacy, LLC, which was acquired by the Company in 2015. Previously as director of Pharmacy Services in Pompano Beach, Florida, he was responsible for sales and distribution of all internet related prescription sales.
Mr. Paul Sharaf
CEO and Co-Founder of Singularis eHealth.
During his 28-year career in healthcare, he has held positions of increasing responsibility with a growing focus on US Market Access challenges. Paul started his career at Eli Lilly and Company where he held positions in Sales, Sales Training, Sales Management, Business Development, Alliance Management, and finished his tenure at Lilly as Director of Operations for the US Market Access business.
Mr. Michael Liocano
Mr. Loiacono, age 55, has more than 25 years of financial management experience, and is currently Chief Financial Officer at Tapimmune, Inc. (NASDAQ:TPIV). TapImmune Inc. is a leader in the development of novel immunotherapies for cancer, with multiple Phase 2 and Phase 1b/2 clinical studies currently ongoing for the treatment of ovarian and breast cancer. At his previous company, FCTI, Inc., Michael was responsible for the company’s strategic development to include new products and services, new market penetration and maximizing gross and net revenues. In 2013, FCTI, Inc. acquired Global Axcess Corp, a publicly-traded company, where Michael served as CFO since 2006.
Mr. John Stowell
Mr. John Stowell, age 56, is currently a Doctor of Business Administration candidate at Georgia State University, expected 2019. Mr. Stowell is a consumer and digital marketing expert having developed new brands and products for leading companies in both B2B and B2C markets. He launched Gold Peak RTD Tea and other consumer brands while employed at the Coca-Cola Company. Currently, Gold Peak sales exceed over $1B globally. He also restaged two mature brands generating four percentage point or greater increases in sales for Nestea and Mitsubishi Electric Cooling and Heating. Stowell has successfully launched over a dozen product lines extensions ranging in size from $10M to over $50M for companies including H.J. Heinz and Zep Inc.
Mr. Stowell earned his Master of Business Administration in marketing from The University of North Carolina, 1990 and a Bachelor of Economics from the University of Oklahoma, 1984.
Mr. Craig Olivas
A consultant and advisor to the Company since 2015. Mr. Olivas is a career digital marketing executive, and owner of Orange Curtain Media, LLC, an Orange County, California based advertising and web technology firm. Mr. Olivas has over 25 years’ experience in e-commerce and web technology, specifically with the regulatory requirements of publicly held companies.
Our Advisory Board participants are non-executives as defined in Section 16 of the Securities Act of 1933.
News & Events
Atlanta, GA, April 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- True Nature Holding, Inc. (OCTQB: TNTY) (the "Company" or "True Nature") provides this update to its shareholders from Company President and Interim CEO, Jim Crone. Dear Shareholders: During fiscal 2018, The Company made significant pro [...]
Jim Crone, President and Interim CFO of True Nature Holding, Inc., is Featured in a New Audio Interview with SmallCapVoice.com
Press Release | 03/18/2019 AUSTIN, Texas, March 18, 2019 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and True Nature Holding, Inc. (OTC.QB: TNTY) (the "Company" or "True Nature"), a development stage company whose mission is to leverage new technologies and services to improve healthcare and outc [...]